Latest News of CRS
Is Carpenter Technology's (CRS) BioDur 108 a High-Performance Alloy with Investment Potential?
The article discusses the growth of the global 3D printing and additive manufacturing market, emphasizing the potential of Carpenter Technology (NYSE:CRS) in this sector. CRS offers innovative materia...
CRISPR Therapeutics AG (CRSP): Among the Worst ARK Stocks According to Short Sellers
The article discusses ARK stocks and Cathie Wood's investment approach, focusing on disruptive innovation. It highlights CRISPR Therapeutics AG (NASDAQ:CRSP) and its potential in the gene sequencing i...
CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote & History - Yahoo Finance
CRISPR Therapeutics AG is a gene editing company using CRISPR/Cas9 technology to develop gene-based medicines for various diseases. Their lead product, CASGEVY, aims to treat genetic blood disorders b...
-
CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote & History
By Yahoo! Finance | 2 months agoCRISPR Therapeutics AG is a gene editing company developing gene-based medicines for various diseases using its CRISPR/Cas9 platform. Their lead product candidate, CASGEVY, focuses on treating hemoglo...
-
CRSR Stock Price | Corsair Gaming Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
By MarketWatch | 2 months agoCorsair Gaming, Inc. is a company specializing in hardware components for personal computers. They provide a range of products in the Gamer and Creator Peripherals and Gaming Components and Systems se...
-
Corsair Gaming, Inc. (CRSR): Are Reddit's WallStreetBets Buying This Stock Now?
By Yahoo! Finance | 2 months agoThe rise of retail investing and surge in online information has democratized investing. Retail investors are reshaping the market, with popular stocks like Corsair Gaming, Inc. (NASDAQ: CRSR) experie...
-
Is CRISPR Therapeutics AG (CRSP) the Best Stock to Buy and Hold for 5 Years?
By Yahoo! Finance | 2 months agoInsider Monkey analyzed Cathie Wood's top stock picks for long-term investment. CRISPR Therapeutics AG (NASDAQ:CRSP) is highlighted as a revolutionary player in genetic sequencing. The company's poten...
-
Carpenter Technology Corporation's (NYSE:CRS) Intrinsic Value Is Potentially 36% Above Its Share Price
By Yahoo! Finance | 3 months agoAn analyst price target for Carpenter Technology Corporation (CRS) is US$118, 13% below fair value. Using a Discounted Cash Flow (DCF) model, the intrinsic value is estimated at US$99.5, indicating th...
-
CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?
By Yahoo! Finance | 3 months agoCRISPR Therapeutics shows promise in gene therapy with its groundbreaking treatments for genetic diseases. Despite challenges like establishing treatment centers and gaining long-term data, the compan...